Nitric oxide and cancer

Journal of Clinical and Diagnostic Research

Volumn 4, Issue 3, 2010, Pages 2550-2559

  Dhankhar, R ^a   Dahiya, K ^a   Singh, V ^a   Sangwan, L ^a   Kaushal, V ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer; Chemotherapy; Nitric oxide; Nitric oxide synthase; Radiotherapy

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER THERAPY; CARCINOGENESIS; ENZYME ACTIVITY; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR GROWTH; TUMOR PROMOTION;

EID: 78650074913     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Jayanta De, Maity CR (2003). Nitric oxide: A magic molecule. Indian J Med Biochem 7: 53-67.
2. Furchgott RF, Khan MT, Jothianandam KM (1987). Similarities of behaviour of metric elaxing factor in a perfusion cascade bioassay system. Fed Proc 46: 385-391.
3. Moncada S, Palmer RMJ, Higgs EA (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142.
4. Beevi SSS, Rasheed AMH, Geetha A (2004). Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 34 (7): 379-385.
5. Wang Y (1995). Nitric oxide synthases: gene structure and regulation. Adv Pharmacol 34: 71-90.
6. Naush LW, Ledoux J, Bones AD, Nelson MT, Dostman WR (2008). Differential patterning of cGMP in vascular smooth muscles revealed by single GFP- linked biosensors. Proc Natl Acad Sci USA 105: 365-380.
7. Vallance P, Leone A, Calver A (1992). Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20: 60-62.
8. Tylor EL, Megson I (2003). Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ 10; 418-430.
9. Lala PK, Orucevic A (1998). Role of nitric oxide in tumour progression: lessons from human tumours. Cancer and Metastasis Review 17: 91-106.
10. Radomski M W, Jenkins DC, Holms L, Moncada C (1991). Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 51: 6073-6078.
11. Fujimoto (1997). Nitric oxide synthases and reactive oxygen species damage in pleural and lung tissues and neoplasia. Jpn J Cancer Res 88:1190-1198.
12. Pan JW, Zhan R, Tong Y, Zhou Y, Zhang M (2005). Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytomas. J Zhejiang Univ Sci B 6:693-698.
13. Zhan JH, Hu XL, Dai CJ, Niu J, Gu JQ (2001). Expressions of p53 and inducible nitric oxide synthase in congenital choledochal cysts and factors of biliary carcinogenesis in choledochal cysts. Eur J Pediatr Surg 11:24-27.
14. Meeta J, Nicholas F, LaRusso, Gregory JG (2001). Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 281:626-634.
15. Vaninetti NM, Geldenhuys L, Porter GA, Risch H, Hainaut P, Guernsey DL, et al (2008). Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinomas. Mol Carcinog 47: 275-285.
16. Maria DB (2006). Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas. World J Gastroenterol 12: 4952-4956.
17. Gunel R, Nazan D, Coskun H, Ugur K, Sancak R, Banu L, et al (2003). Prognostic Value of Serum IL-18 and Nitric Oxide Activity in Breast Cancer Patients at Operable Stage. Am J Clin Oncol 26: 416-421.
18. MacLeod CL (2001). Nitric Oxide and Arginine in Normal and Tumorous Breast. J Biol Chem 276: 881-885.
19. Brandao MM, Soares E, Salles TS, Saad ST (2001). Expression of inducible nitric oxide synthase is increased in acute myeloid leukemia. Acta Haematol 106: 95-99.
20. Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, et al (1998). B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying antiapoptotic activity. Blood 92:1031-1043.
21. Radomski MW, Palmer RMJ, Moncada S (1990). An L-arginine/nityric oxide pathway, present in human plateletes aggregation. Proc Natl Acad Sci USA 87:5193-5197.
22. Dawson TM, Dawson VL (1995). Nitric oxide: Actions and pathological roles. Neuroscientist 1: 1-19.
23. Gross SS, Volin MS (1995). Nitric oxide: Pathological mechanisms. Ann Rev Physiol 57: 737-769.
24. Li L, Kilborn RG, Adams J, Fidler IJ (1991). Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51: 2531-2535.
25. Nathan C, Xie QW (1994). Nitric oxide synthetases: roles, toles and controls. Cell 78: 815-919.
26. Cui S, Reichner JS, Mateo RB, Albina JE (1994). Activated murine macrophages induce apoptosis in tumor cells through nitric oxidedependent or-independent mechanisms. Cancer Res 54: 2462-2467.
27. Weigert A, Brune B (2008). Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric oxide and Cancer: Clinical and Therapeutic Implications 2 (19): 95-102.
28. Brune B, Knethen A, Sandau KB (1999). Nitric oxide (NO): an effector of apoptosis. Cell Death Differentiation 6: 969-975.
29. Xie K, Huang S, Dong Z, Gutman M, Fidler IJ (1995). Direct correlation between expression of endogenous inducible nitric oxide synthetase and regression of M5076 hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 55: 3123-3131.
30. Dong Z, Staroselsky AH, Qi X, Xie K, Fidler IJ (1994). Inverse correlation between expression of inducible nitric oxide synthetase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54: 789-793.
31. Palmer PMJ, Rees DS, Ashton DS, Moncada C (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (Lond) 333: 664-666.
32. Sakkoula E, Haralabopoulos G, Andriopolou P, Peristeris P, Maragoudakis ME (1994). Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902.
33. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150: 5080-5085.
34. Hibbs JB Jr, Taintor RR, Vavrin Z (1987). Macrophage cytotoxicity: role for Larginine deiminase and imino nitrogen oxidation to nitrite. Science 235:473-476.
35. Jenkins DC, Charles IG, Thomsen LL, et al (1995). Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92:4392-4396.
36. Ambs S, Merriam WG, Ogunfusika MO, et al (1998). p53 and vascular endothelial growth factor regulate tumor growth of NOS2- expressing human carcinoma cells. Nat Med 4:1371-1376.
37. Maeda H, Akaide T (1998). Nitric oxide and oxygen radicals in infection, inflammation and cancer. Biochemistry (Moscow) 7: 1007-1019.
38. Ambs S, Hussain SP, Harris CC (1997). Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 11: 443-448.
39. Thomsen LL, Miles D (1998). Role of nitric oxide in human progression: lessons from human tumours. Cancer Met Rev 17: 107-118.
40. Hassan MS, Mileva M, Dweck H, Rosenfeld L (1998). Nitric oxide products degrade chondroitin sulfates. Nitric oxide: Biology and chemistry, 215, 1998, 360-365.
41. Chinje EC, Stratford IJ (1997). Role of nitric oxide in growth of solid tumors: a balancing act. Essays Biochem 32: 61-72.
42. Xie K, Dong Z, Fidler IJ (1996). Activation of nitric oxide synthetase gene for inhibition of cancer metastasis. J Leuk Biol 59: 797-803.
43. Murta BMT, Machado JS, Zaparoli M, Lara VC, Murta EFC (1999). The relationship of host immune cells, cytokines and nitric oxide production to tumor cells in ovarian carcinoma. - Sao Paulo Med J 2: 87-92.
44. Xu W, liu LZ, loizidou M, Ahmed M, charles IG (2002). The role of nitric oxide in cancer. Cell Research 12: 311-320.
45. Xie K, Huang S, Dong Z. et al (1995). Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181:1333-1343.
46. Juang SH, Xie K, Xu L, et al (1998). Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum Gene Ther 9:845-885.
47. Tzeng E, Yoneyama T, Hatakeyama K, Shears LL, 2nd & Billiar TR (1996). Vascular inducible nitric oxide synthase gene therapy: requirement for guanosine triphosphate cyclohydrolase I. Surgery 120:315-321.
48. Miles DW, Thomsen LL, Balkwill, Thavasu P, Moncada S (1994). Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin- 2. Eur J Clin Invest 24: 287-290.
49. Alexandrova R, Mileva M, Zvetkova E. Nitric oxide and Cancer (Minireview) (2001). Exp Path Parasitol 4/7: 13-18.
50. Zidek Z, Masek K (1998). Erratic behavior of nitric oxide within the immune system: illustrative review of conflicting data and their immunopharmacological aspects. Int J Immunopharmacol 20: 319-343.
51. Howard-Flanders P (1957). Effect of nitric oxide on the radiosensitivity of bacteria. Nature 180: 1191-1192.
52. Mitchell J B, Wink DA, DeGraff W, Gamson J, Keefer LK, Krishna MC (1993). Activation of inducible nitric oxide synthase results in nitric oxide mediated radiosensitization of hypoxic EMT-6 tumor cells. Cancer Res 53: 5845-5848.
53. Christos H (2003). Nitric oxide: A new concept in radiopharmacology. Journal of BUON 8: 209-216.
54. Wink D A, Vodovotz Y, Cook J A, Krishna M C, Kim S, Coffin D, DeGraff W, Deluca A M, Liebmann J, Mitchell J B (1998). The role of nitric oxide chemistry in cancer treatment. Biochemistry 63(7): 802-809.